Clinical Trial Update: Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes

View source ↗

Summary

Real-world Canadian retrospective study evaluating long-term semaglutide use and its cardio-kidney-metabolic outcomes. Sponsor: LMC Diabetes & Endocrinology Ltd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Diabetes (DM), Type 2 Diabetes | Status: NOT_YET_RECRUITING